Table 2.

Patient characteristics.

id	Disease type	Disease stage	Age	Sex	FAB subtype: cytogenetics	% blasts in bone marrow	PASD1 status	HLA-A2 status
I	AML	diagnosis	58	F	M2: 47, XX, +8	72%	+	+
II	AML	diagnosis	57	M	M1: complex cytogenetics	32%	+	+
III	AML	remission	25	M	M2: 46, XY, t (6,17) (p21,q21)	50%	−	+
IV	AML	diagnosis (post-DA)‡	25	M	M5: complex cytogenetics	22%	+	+

^‡- patient received a single course of daunorubicin and cytarabine but did not respond to treatment.